Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
Basic
4
Ṁ1052026
38%
chance
1D
1W
1M
ALL
This category of drug is finding more and more uses for a variety of conditions, but the history of drugs, and weight loss drugs in particular, is legally fraught (Phen-Fen, etc.) Are we irrationally exuberant about GLP1 or is it different this time?
Get
1,000and
1.00
1,0001.00Related questions
Related questions
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
48% chance
Will a drug designed with significant contribution from an AlphaFold-like system pass a Phase I trial by end of 2025?
37% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will Lantern Biotech get sued for over $1M by 2029?
36% chance
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will a publicly listed pharma company reach $1T in market cap before 2025?
51% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
84% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
75% chance